International debate about human genome editing governance has undergone a paradigm shift and suggests that inclusive public deliberation is still important.
AMA J Ethics. 2019;21(12):E1065-1070. doi:
10.1001/amajethics.2019.1065.
Jonathan Alhalel, Nicolás Francone, Sharon Post, Catherine A. O’Brian, PhD, and Melissa A. Simon, MD, MPH
Underrepresentation of individuals with limited English proficiency who speak Spanish is ongoing in phase 3 biomedical clinical trials and exacerbates health inequity.
AMA J Ethics. 2022;24(4):E319-325. doi:
10.1001/amajethics.2022.319.
Conflicts of interest must be acknowledged with sincerity and earnestness and managed such that the conflict is eliminated or, at least, credibly mitigated.
AMA J Ethics. 2023;25(3):E186-193. doi:
10.1001/amajethics.2023.186.
Wendy E. Parmet, JD and Claudia E. Haupt, PhD, JSD
Clinicians using governing authority to make public health policy are ethically obliged to draw upon scientific and clinical information that accords professional standards.
AMA J Ethics. 2023;25(3):E194-199. doi:
10.1001/amajethics.2023.194.
Spread of health misinformation by health professionals who also hold government positions represents a long-standing problem exacerbated during the COVID-19 pandemic.
AMA J Ethics. 2023;25(3):E210-218. doi:
10.1001/amajethics.2023.210.